Clinical Trial Update: 3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study [Phase 3]

View source ↗

Summary

A Phase 3 follow-up trial investigating viral activity in chronic hepatitis C patients who previously failed feeder DEB025/Alisporivir; the study is terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Feeder DEB025 (alisporivir)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hepatitis C, Chronic | Phase 3 | Status: TERMINATED | Results posted: 2018-01-12